Search - tctmd.com

Displaying 101 - 120 of 135

Sort: Relevancy | Date

Presentation

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Presenter: C.T. Ruff

December 15, 2013

Presentation

New Oral Anticoagulants and the Risk of Intracranial Hemorrhage

Presenter: Saurav Chatterjee

December 15, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

Presentation TCT 2013

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

Reversal Strategies Warfarin and the New Oral Anticoagulants: How Necessary, How Fast, How Safe, How Effective?

Presenter: Kurt Huber

October 31, 2013

Presentation TCT 2013

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Presenter: Ori Ben-Yehuda

October 31, 2013

Presentation TCT 2013

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Presenter: Jonathan Halperin

October 31, 2013

Presentation TCT 2013

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Presenter: Pascal Vranckx

October 31, 2013

Presentation TCT 2013

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Presenter: Christopher Granger

October 27, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

Presentation VEINS 2013

Switching Patients to the New Anticoagulants

Presenter: Suman Rathbun

September 21, 2013

Presentation SOLACI 2013

Evolução da Terapêutica Anticoagulante na SCA: Uma Nova Era

Presenter: Ot?vio Rizzi Coelho

July 25, 2013

Presentation Fellows 2013

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Presenter: Manesh Patel

April 16, 2013

Presentation TCT 2013

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Presenter: Andr?s Kom?csi, Andr?s Vorobcsuk, D?niel Kehl, Daniel Aradi

January 31, 2013

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Advertisement

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

New Oral Anticoagulants and the Risk of Intracranial Hemorrhage

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Reversal Strategies Warfarin and the New Oral Anticoagulants: How Necessary, How Fast, How Safe, How Effective?

Pulmonary Embolism: When to Use Lytics, When to Use Novel Oral Anticoagulants

Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know to Use Them Safely

Dual Anti-Platelet Therapy Plus the New Chronic Oral Anticoagulants: What Do We Know?

Who Should Receive the New Chronic Oral Anticoagulants? Which One?

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Switching Patients to the New Anticoagulants

Evolução da Terapêutica Anticoagulante na SCA: Uma Nova Era

Navigating the New Chronic Oral Anticoagulants and How to Deal with Triple Therapy

Novel oral anticoagulants in patients with acute coronary syndromes: meta-analysis of randomized controlled trials

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Part 1: Oral Anticoagulants

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content